Trevi Therapeutics | 8-K:重大事件
Trevi Therapeutics | 4:持股变动声明-高管 Galletta Christopher
Trevi Therapeutics | 8-K:重大事件
Trevi Therapeutics | 424B5:募资说明书
Trevi Therapeutics | 8-K:重大事件
Trevi Therapeutics | 8-K:重大事件
Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%)等
Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rubric Capital Management LP(6.92%),David Rosen(6.92%)
Trevi Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-New Enterprise Associates 16, L.P.(18.7%),NEA Partners 16, L.P.(18.7%)等
Trevi Therapeutics | 10-Q:2024财年三季报
Trevi Therapeutics | 8-K:Trevi Therapeutics公布2024年第三季度财务业绩并提供业务最新情况
Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-James N. Topper(10.2%),Patrick J. Heron(10.2%)等
Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rosalind Advisors, Inc.(1.03%),Steven Salamon(1.03%)等
Trevi Therapeutics | 8-K:重大事件
Trevi Therapeutics | 8-K:重大事件
Trevi Therapeutics | 4:持股变动声明-高管 Cassella James V
Trevi Therapeutics | 8-K:重大事件
Trevi Therapeutics | 4:持股变动声明-高管 GOOD JENNIFER L
Trevi Therapeutics | 4:持股变动声明-高管 GOOD JENNIFER L
Trevi Therapeutics | 144:拟议出售证券